Enzyme Inhibitors: Competitive and Non-Competitive Control | 酶抑制剂:竞争性与非竞争性调控

📚 Enzyme Inhibitors: Competitive and Non-Competitive Control | 酶抑制剂:竞争性与非竞争性调控

Enzyme inhibitors are molecules that reduce the rate of an enzyme-catalysed reaction by binding to the enzyme. They do not necessarily destroy the enzyme; many act reversibly and are essential in controlling metabolism. Understanding inhibitors is central to A-Level Biology because it links enzyme structure, reaction kinetics, drug action, and metabolic regulation.

酶抑制剂是一类通过结合酶来降低酶促反应速率的分子。它们不一定破坏酶;许多抑制剂以可逆方式起作用,并在代谢调控中发挥重要作用。理解抑制剂是 A-Level 生物学的核心内容,因为它将酶的结构、反应动力学、药物作用与代谢调控联系起来。

1. What Are Enzyme Inhibitors? | 什么是酶抑制剂?

An enzyme inhibitor is a substance that binds to an enzyme and decreases its catalytic activity. Inhibition may be reversible or irreversible, and it can occur at the active site or at another region called the allosteric site.

酶抑制剂是指能与酶结合并降低其催化活性的物质。抑制作用可以是可逆的,也可以是不可逆的;它可以发生在活性位点,也可以发生在别构位点。

Inhibitors can be naturally occurring metabolites, drugs, or poisons. They often reduce the formation of enzyme-substrate complexes or prevent the enzyme from converting substrate into product.

抑制剂可以是天然代谢物、药物或毒物。它们通常会减少酶-底物复合物的形成,或阻止酶将底物转化为产物。


2. Why Inhibition Matters | 抑制的重要性

Cells must switch enzymes on or off to avoid wasting energy and to respond to changing conditions. Inhibitors provide a rapid and reversible way to control enzyme activity without changing the amount of enzyme present.

细胞必须开启或关闭酶,以避免浪费能量并应对外界条件变化。抑制剂提供了一种快速且可逆的酶活性控制方式,无需改变酶的数量。

In medicine, many drugs act as enzyme inhibitors. For example, they can block a pathogen’s essential enzyme or reduce an overactive pathway in the body. In agriculture and toxicology, inhibitors are also used as pesticides and can act as poisons.

在医学中,许多药物通过充当酶抑制剂起作用,例如阻断病原体的关键酶或降低体内过度活跃的代谢途径。在农业和毒理学中,抑制剂也被用作杀虫剂,并可能成为毒物。


3. Reversible vs Irreversible Inhibition | 可逆抑制与不可逆抑制

Reversible inhibitors bind through weak non-covalent interactions such as hydrogen bonds, ionic bonds, or hydrophobic interactions. They can dissociate from the enzyme, so enzyme activity is restored when the inhibitor is removed.

可逆抑制剂通过氢键、离子键或疏水相互作用等较弱的非共价作用结合。它们可以从酶上解离,因此去除抑制剂后酶活性得以恢复。

Irreversible inhibitors form strong covalent bonds with amino acid side chains at or near the active site, permanently blocking catalysis. The enzyme is usually inactivated and cannot be restored simply by removing the inhibitor.

不可逆抑制剂与活性位点内部或附近的氨基酸侧链形成牢固的共价键,永久性地阻断催化作用。酶通常会失活,仅靠移除抑制剂无法恢复。

Competitive and non-competitive inhibitors are usually reversible, but some poisons and drugs such as aspirin and penicillin act irreversibly. Both reversible and irreversible inhibition can be biologically important.

竞争性和非竞争性抑制剂通常是可逆的,但一些毒物和药物如阿司匹林、青霉素则不可逆地起作用。可逆抑制和不可逆抑制都具有重要的生物学意义。


4. Competitive Inhibitors: Mechanism | 竞争性抑制剂的作用机制

A competitive inhibitor has a shape and charge distribution similar to the substrate. It binds reversibly to the active site, forming an enzyme-inhibitor complex, but it cannot be converted into product.

竞争性抑制剂具有与底物相似的形状和电荷分布。它可逆地结合到活性位点,形成酶-抑制剂复合物,但无法转化为产物。

Because the inhibitor and substrate compete for the same active site, the degree of inhibition depends on the relative concentrations of substrate and inhibitor. If the inhibitor concentration is high, it occupies more active sites and reduces the reaction rate.

由于抑制剂和底物竞争同一个活性位点,抑制程度取决于底物与抑制剂的相对浓度。如果抑制剂浓度较高,就会占据更多活性位点,从而降低反应速率。

Increasing substrate concentration can outcompete the inhibitor, so the maximum reaction rate can still be reached if enough substrate is present.

提高底物浓度可以竞争胜过抑制剂,因此只要有足够的底物,仍可达到最大反应速率。


5. Competitive Inhibitors: Kinetics and Graph | 竞争性抑制剂的动力学与曲线

On a rate-substrate concentration graph, a competitive inhibitor shifts the curve to the right. At low substrate concentration, the rate is reduced because the inhibitor occupies active sites; at very high substrate concentration, the inhibitor is displaced and Vmax is unchanged.

在反应速率-底物浓度图中,竞争性抑制剂使曲线向右移动。在低底物浓度下,由于抑制剂占据活性位点,反应速率降低;在很高底物浓度下,抑制剂被取代,Vmax 不变。

The apparent Kₘ increases because a higher substrate concentration is needed to reach half the maximum rate. This indicates reduced apparent affinity of the enzyme for its substrate in the presence of the inhibitor.

表观 Kₘ 增大,因为需要更高的底物浓度才能达到最大速率的一半。这说明存在抑制剂时,酶对底物的表观亲和力下降。

In simple terms, competitive inhibition can be overcome by flooding the enzyme with substrate, so the final maximum rate remains the same as the uninhibited reaction.

简单来说,竞争性抑制可以通过大量增加底物来克服,因此最终的最大速率与未抑制反应相同。


6. Examples of Competitive Inhibition | 竞争性抑制实例

A classic example is malonate, which inhibits succinate dehydrogenase in the Krebs cycle. Succinate dehydrogenase normally oxidises succinate to fumarate; malonate is structurally similar to succinate and competes for the active site.

一个经典例子是丙二酸,它抑制克雷布斯循环中的琥珀酸脱氢酶。琥珀酸脱氢酶通常将琥珀酸氧化为延胡索酸;丙二酸与琥珀酸结构相似,竞争活性位点。

Sulfonamide antibiotics inhibit an enzyme involved in bacterial folic acid synthesis. They are structurally similar to p-aminobenzoic acid (PABA), so they compete for the active site and block folic acid production, slowing bacterial growth.

磺胺类抗生素抑制参与细菌叶酸合成的酶。它们的结构与对氨基苯甲酸(PABA)相似,因此竞争活性位点并阻断叶酸生成,从而抑制细菌生长。

Another medical example is statins, which are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis.

另一个医学例子是他汀类药物,它们是胆固醇合成限速酶 HMG-CoA 还原酶的竞争性抑制剂。


7. Non-Competitive Inhibitors: Mechanism | 非竞争性抑制剂的作用机制

A non-competitive inhibitor does not compete with the substrate for the active site. It binds to a different region of the enzyme, called the allosteric site, and changes the three-dimensional shape of the enzyme.

非竞争性抑制剂不竞争底物的活性位点。它结合在酶的另一区域,即别构位点,从而改变酶的三维形状。

This conformational change distorts the active site so that the substrate can often still bind, but cannot be converted into product efficiently. In some cases, the substrate may not bind at all.

这种构象变化使活性位点变形,因此底物通常仍能结合,但无法有效转化为产物;有时底物甚至完全不能结合。

Increasing substrate concentration cannot overcome non-competitive inhibition because the inhibitor and substrate do not bind to the same site. The inhibitor remains bound regardless of how much substrate is present.

提高底物浓度无法克服非竞争性抑制,因为抑制剂和底物结合的位点不同。无论底物有多少,抑制剂仍然保持结合。


8. Non-Competitive Inhibitors: Kinetics and Graph | 非竞争性抑制剂的动力学与曲线

On a rate-substrate concentration graph, a non-competitive inhibitor lowers the maximum rate Vmax. The curve rises more slowly and plateaus at a lower value than the uninhibited enzyme.

在反应速率-底物浓度图中,非竞争性抑制剂降低最大反应速率 Vmax。曲线上升更慢,并且平台值低于未抑制的酶。

For many simple non-competitive inhibitors, Kₘ remains approximately unchanged because binding of the inhibitor does not directly block substrate binding at the active site. The enzyme still shows similar affinity for the substrate.

对于许多简单的非竞争性抑制剂,Kₘ 基本保持不变,因为抑制剂结合并不直接阻断底物与活性位点结合;酶对底物的亲和力仍相似。

However, the catalytic turnover is impaired, so even an infinite substrate concentration cannot restore the original maximum rate.

然而,催化转换受到损害,因此即使底物浓度无限增大,也无法恢复到原来的最大速率。


9. Examples of Non-Competitive and Irreversible Inhibition | 非竞争性抑制与不可逆抑制实例

Heavy metal ions such as Hg²⁺, Ag⁺, and Pb²⁺ can act as non-competitive inhibitors. They often bind to cysteine side chains containing –SH groups, disrupting tertiary structure and the shape of the active site.

汞离子 Hg²⁺、银离子 Ag⁺ 和铅离子 Pb²⁺ 等重金属离子可作为非竞争性抑制剂。它们常与含 –SH 基团的半胱氨酸侧链结合,破坏三级结构和活性位点形状。

Cyanide is a potent inhibitor of cytochrome c oxidase in the electron transport chain. It binds tightly to the enzyme and stops ATP production, which is why cyanide is highly toxic.

氰化物是电子传递链中细胞色素 c 氧化酶的强抑制剂。它与酶紧密结合,阻止 ATP 生成,因此氰化物具有剧毒。

These examples show that non-competitive and irreversible inhibitors often have severe effects because they cannot be easily overcome by changing substrate concentration.

这些例子表明,非竞争性和不可逆抑制剂往往会产生严重后果,因为它们不能通过改变底物浓度来轻易克服。


10. End-Product Inhibition | 末端产物抑制

Many metabolic pathways are controlled by end-product inhibition, a form of negative feedback. The final product of a pathway acts as a reversible non-competitive inhibitor of the first enzyme in the pathway.

许多代谢途径通过末端产物抑制进行调控,这是一种负反馈形式。途径的最终产物作为途径中第一个酶的可逆非竞争性抑制剂。

For example, in the synthesis of isoleucine from threonine, isoleucine binds to the allosteric site of threonine deaminase and inhibits its activity when isoleucine is abundant.

例如,在从苏氨酸合成异亮氨酸的途径中,当异亮氨酸充足时,异亮氨酸结合到苏氨酸脱氨酶的别构位点并抑制其活性。

This prevents wasteful accumulation of products and keeps intermediates at balanced levels. It allows cells to respond quickly to their own metabolic needs.

这可以防止产物过量积累,并使中间产物保持在平衡水平。它使细胞能够快速响应自身的代谢需求。


11. Inhibitors in Medicine and Poisons | 抑制剂在医学与毒物中的应用

Many drugs are reversible or irreversible enzyme inhibitors. Aspirin irreversibly acetylates the enzyme cyclooxygenase (COX), reducing the production of prostaglandins that cause pain and inflammation.

许多药物是可逆或不可逆酶抑制剂。阿司匹林不可逆地乙酰化环氧合酶(COX),减少引起疼痛和炎症的前列腺素生成。

Penicillin irreversibly inhibits transpeptidase, an enzyme bacteria need to build their cell walls. Without functional cell walls, bacterial cells burst and die.

青霉素不可逆地抑制转肽酶,这是细菌构建细胞壁所需的一种酶。没有功能性的细胞壁,细菌细胞会破裂死亡。

Some pesticides and nerve gases are also enzyme inhibitors. For example, organophosphates inhibit acetylcholinesterase, causing overstimulation of muscles and nerves.

一些杀虫剂和神经毒气也是酶抑制剂。例如,有机磷化合物抑制乙酰胆碱酯酶,导致肌肉和神经过度兴奋。


12. Summary Comparison Table | 总结对比表

The table below summarises the key differences between competitive and non-competitive inhibitors at A-Level. Use it for quick revision before exams.

下表总结了 A-Level 中竞争性抑制剂与非竞争性抑制剂的主要区别,适合考前快速复习。

Feature | 特征 Competitive | 竞争性 Non-Competitive | 非竞争性
Binding site | 结合位点 Active site | 活性位点 Allosteric site | 别构位点
Shape similarity to substrate | 与底物形状相似性 Similar | 相似 Different | 不同
Effect of increasing substrate | 增加底物的效果 Overcomes inhibition | 可克服抑制

Published by TutorHao | A-Level Biology Revision Series | aleveler.com

更多咨询请联系16621398022(同微信)

Comments

屏轩国际教育cambridge primary/secondary checkpoint, cat4, ukiset,ukcat,igcse,alevel,PAT,STEP,MAT, ibdp,ap,ssat,sat,sat2课程辅导,国外大学本科硕士研究生博士课程论文辅导

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from aleveler.com

Subscribe now to keep reading and get access to the full archive.

Continue reading